Gerald E. Commissiong
CEO, President & DirectorMr. Gerald E. Commissiong serves as Chief Business Officer at OS Therapies Incorporated since April 2024. Mr. Commissiong is Chief Business Officer of DataMEDS AI, Inc. (formerly known as Wellgistics Health, Inc.) from February 2026 and serves as its Interim Co-Chief Executive Officer from May 20, 2026. He serves as the President and CEO of Tollo Health. He served as an Advisor and Strategic Consultant at International Infusion, Inc. He serves as the Chief Executive Officer and Director at Todos Medical Ltd. since January 5, 2020 and also serves as its President. He also currently acts as a Managing Partner at Fortitude Advisors LLC since January 2019. Mr. Commissiong had been the Chief Executive Officer and President of Amarantus Bioscience Holdings, Inc. since October 23, 2011. He is interim- Chief Executive Officer of Breakthrough Diagnostics, Inc., Todos’ joint venture with Amarantus. Mr. Commissiong served as an Interim Chief Executive Officer and Director of Amarantus Diagnostics, Inc. He served as the Chief Operating Officer of Amarantus BioScience Holdings, Inc since April 2011 and also served as its Chief Business Officer. He Co-Founded it in 2008 and has played a critical role in its development. From the inception of the company, he attracted seed capital, acquired the intellectual property rights and recruited scientific and executive talent to allow for the further development of the companies technologies. He served as the Chief Executive Officer and President of Amarantus BioScience Holdings, Inc. Mr. Commissiong was responsible for building the infrastructure to move its lead candidate forward for the treatment of Parkinson's disease. He has expertise in Public and Private Finance. In 2007, he was a professional athlete with the Calgary Stampeders of the Canadian Football League. He had been a Director of Amarantus BioScience Holdings, Inc since April 2011. He served as an Executive Director of Avant Diagnostics, Inc. from May 12, 2016 to August 25, 2017. He served as Interim Chief Executive Officer of Cutanogen Corporation. Mr. Commissiong holds a B.Sc. degree in Management Science and Engineering with a focus on Financial Decisions from Stanford University.
Positions
- Company NameTodos Medical Ltd.Stock CodeTOMDFPositionCEO, President & Director
- Company NameOS Therapies IncorporatedStock CodeOSTXPositionChief Business OfficerColleagues
- PAPaul A. RomnessFounder, Chairman, President & CEO
- RGRobert G. PetitChief Medical Officer & Chief Scientific Officer
- FKFrancis KnuettelChief Financial Officer
- JDJack DollChief of Staff
- GEGerald E. CommissiongChief Business Officer
- JCJohn CiccioIndependent Director
- TFTheodore F. SearchIndependent Director
- JWJutta WannerMember of Antibody Drug Conjugate (ADC) Advisory Board
- OEOlivia EggeMember of Patient Advocacy Advisory Board
- Company NameDataMEDS AI, Inc.Stock CodeMEDSPositionInterim Co-CEO & Chief Business OfficerColleagues
- PPPrashant PatelInterim Co-CEO, President & Director
- SKSurendra K. AjjarapuChairman of the Board
- EMEric Michael SherbInterim-CFO
- GEGerald E. CommissiongInterim Co-CEO & Chief Business Officer
- BTBrett ThompsonChief Technology Officer
- SPShafaat PiraniChief Clinical Officer
- GLGary L. HermanIndependent Director
- DGDonald G. FellIndependent Director
- MVMarlene VelezIndependent Director
